Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent underwhelming data for CagriSema, but the Danish pharma has given itself ...

The FDA has issued a warning about counterfeit Ozempic injections circulating in the U.S., urging consumers to check labels ...

FDA-approved Wegovy® at a reduced cost in our high-quality pen." Wegovy is a highly popular medication due to its weight-loss benefits. In previous years, Novo Nordisk struggled to meet the demand for ...

The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several ... Its weight-loss drug Wegovy also has the same active ingredient. As the investigation continues, further ...

Novo Nordisk Expands Discounted Wegovy Price to Brick-and-Mortar Pharmacies ... pre-filled injection pens. The new lower cash price for Wegovy covers all doses of the drug. As with the online ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...

Danish pharmaceutical company Novo Nordisk plans to introduce its weight-loss drug Wegovy in India earlier than planned to ...

The Centres for Medicare and Medicaid Services on Friday said that it did not move forward with a proposal put forward by the ...

The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.